Live feed
Filing
SC 13G
SC 13G0000902664-20-001843·ADAGE CAPITAL PARTNERS GP, L.L.C.
Schedule 13G ownership disclosure
BIOCRYST PHARMACEUTICALS INC
Security class unavailable · CUSIP: 09058V103
Event date: 2020-04-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,500,000
- Percent of class
- 1.6200%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-20-001843
- Form type
- SC 13G
- Filer
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- CIK
- CIK 1165408
- Filed
- Apr 17, 2020
- Reporting period
- Apr 08, 2020
- Description
- Schedule 13G beneficial ownership